5 Health Services Stocks Nudging The Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 5 points (0.0%) at 15,100 as of Thursday, May 9, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,176 issues advancing vs. 1,742 declining with 136 unchanged.

The Health Services industry currently sits down 0.21 versus the S&P 500, which is down 0.21. Top gainers within the industry include Mindray Medical International ( MR), up 2.3%, and Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.3%. On the negative front, top decliners within the industry include Orthofix International N.V ( OFIX), down 16.31, HCA Holdings ( HCA), down 1.43, DaVita HealthCare Partners ( DVA), down 1.24 and UnitedHealth Group ( UNH), down 1.22.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today:

5. Edwards Life ( EW) is one of the companies pushing the Health Services industry higher today. As of noon trading, Edwards Life is up $1.13 (1.73) to $66.58 on average volume Thus far, 533,045 shares of Edwards Life exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $65.11-$66.60 after having opened the day at $65.43 as compared to the previous trading day's close of $65.45.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $7.2 billion and is part of the health care sector. The company has a P/E ratio of 20.2, above the S&P 500 P/E ratio of 17.7. Shares are down 27.4% year to date as of the close of trading on Wednesday. Currently there are 8 analysts that rate Edwards Life a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Edwards Life Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

4. As of noon trading, Stryker Corporation ( SYK) is up $0.39 (0.59) to $66.84 on light volume Thus far, 392,836 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $66.32-$66.86 after having opened the day at $66.45 as compared to the previous trading day's close of $66.45.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $25.1 billion and is part of the health care sector. The company has a P/E ratio of 20.3, above the S&P 500 P/E ratio of 17.7. Shares are up 21.2% year to date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Stryker Corporation a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

3. As of noon trading, St Jude Medical ( STJ) is up $0.38 (0.90) to $42.80 on light volume Thus far, 620,142 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.5 million shares. The stock has ranged in price between $42.30-$42.87 after having opened the day at $42.30 as compared to the previous trading day's close of $42.42.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $11.8 billion and is part of the health care sector. The company has a P/E ratio of 16.6, below the S&P 500 P/E ratio of 17.7. Shares are up 17.4% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, notable return on equity, attractive valuation levels, growth in earnings per share and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full St Jude Medical Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

2. As of noon trading, Boston Scientific ( BSX) is up $0.26 (3.31) to $8.11 on heavy volume Thus far, 14.5 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 18.0 million shares. The stock has ranged in price between $7.87-$8.15 after having opened the day at $7.89 as compared to the previous trading day's close of $7.85.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $10.4 billion and is part of the health care sector. Shares are up 37.0% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share. Get the full Boston Scientific Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

1. As of noon trading, Intuitive Surgical ( ISRG) is up $14.48 (2.96) to $503.79 on light volume Thus far, 181,795 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 504,900 shares. The stock has ranged in price between $490.00-$507.49 after having opened the day at $490.22 as compared to the previous trading day's close of $489.31.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $19.7 billion and is part of the health care sector. The company has a P/E ratio of 28.8, above the S&P 500 P/E ratio of 17.7. Shares are down 0.1% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Asian Markets Decline in Morning Trading

Asian Markets Decline in Morning Trading

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call